1)A very attractive company in the space of Pharma
2)Growth rate, operating profit is facing multiyear resistance.
3)Net sales, operating profits have improved.
4)A good company to invest in for long term, FII's hold upto 36% stake(Source-BSE)
1)Stock is in resistance zone and if it survives this zone, a good shoot up is expected from...